CDEK
← All trials

NCT07253285

Phase 3Interventional

Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jan 8, 2026
Primary completion
Mar 20, 2030
Completion date
Sep 20, 2033
First posted
Nov 28, 2025
Last posted
Nov 28, 2025
Enrollment
460
Arms / groups
4 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.